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Pharmacologic Modulation of Motility
Richard W. McCalluma
Department of Gastroenterology and Hepatology, Center for GI Motility Disorders,
University ofKansas Medical Center, Kansas City, Kansas
Etiologically, gastroesophageal reflux disease (GERD) can be regarded as motility disorder.
Although blocking acid is effective in the treatment ofGERD, it does not overcome the underlying
pathologicfactors that allow acid, pepcin, and bile torejfux into the esophagus. Prokinetic agents
address the upper gastrointestinal motility disturbances contributing to GERD and, thus, have an
important role in the short- and long-term medical management ofreflux esophagitis. This paper
discusses the rationalefor the effectiveness ofpharmacologic modulation by reviewing current con-
cepts andpostulated theories about the mechanisms underlying the neuromuscular abnormalities.
The multifactorial aspects ofGERD are addressed and the potentialfor tailoring medical therapy
also emphasized.
ESOPHAGEAL MOTOR ACTIVITY
IN REFLUX ESOPHAGITIS
Because acid is the major noxious
agent in the refluxate material, the severi-
ty of esophagitis depends on the duration
of time the esophagus is exposed to acid
material. The esophageal acid exposure
time oracid reflux time is afunction ofthe
frequency ofreflux episodes, as well as the
duration of each reflux episode. The fre-
quency ofreflux episodes is determined by
the factors that impair the antireflux barri-
er. On the other hand, the ability to clear
individual acid reflux episode and acid
clearance time is determined by peristaltic
activity ofthe esophagus and salivary neu-
tralization capacity.
Helm et al. have contributed signifi-
cantly to our understanding of the various
factors that are important in the acid clear-
ance times. The methodology uses the
introduction of a small bolus of acid into
the esophagus (usually 15 ml) and then
asking the individual to swallow at 30 sec
intervals. With the introduction of
hydrochloric acid into the esophagus, the
esophageal pH usually decreases to 1.2,
and acid clearance time is usually counted
as the time forthe esophageal pH to recov-
er to 4. The bolus or volume clearance can
also be measured with the acid clearance
by labeling the acid with radioactive mate-
rial (usually technetium) and monitoring
the radioactivity in the esophagus and
esophageal pH simultaneously.
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Normally, one or two peristaltic con-
tractions clears most ofthe bolus from the
esophagus into the stomach without
changing the esophageal pH. This initial
clearance of bolus is termed the volume
clearance. Once the majority of the vol-
ume of acid is cleared from the esopha-
gus, usually a small amount ofacid sticks
to the surface ofthe mucosa ofthe esoph-
agus and the pH probe. This is cleared
with subsequent swallows (acid neutral-
ization). It is the saliva accompanying
swallows that neutralizes acid and
restores the esophageal pH to normal.
Replacing saliva with water markedly
prolongs acid clearance. These observa-
tions suggest that there are substances in
the saliva that can neutralize acid in the
esophagus. Fifty percent of the buffering
capacity of saliva can be attributed to the
salivary proteins. Reduction of salivary
flow by atropine markedly prolongs acid
clearance time, and agents such as
bethanechol and oral lozenges that stimu-
late salivary flow and bicarbonate produc-
tion markedly accelerates acid clearance
times. Acid clearance time is markedly
prolonged during sleep when salivation
ceases.
Volume clearance and acid neutral-
ization are both important in the clearance
of acid from the esophagus. The impor-
tance of volume clearance can be recog-
nized by the fact that a 15 ml bolus ofacid
would require 105 ml ofsaliva for its neu-
tralization in the absence of a volume
clearance mechanism. With the rate of
basal salivary flow, which is approximate-
ly 1 ml per minute, it would take 1 hr and
45 min for its neutralization. However,
with bolus clearance, 10 to 15 swallows at
30 sec intervals return the esophageal pH
to normal.
Is salivary flow impaired in patients
wit reflux esophagitis? A study by
Sonnenberg et al. showed that there was
no difference in the resting salivary func-
tion among normal subjects and patients
with reflux disease. However, salivary
flow is reduced with age. Smoking dimin-
ishes the salivary flow and its bicarbonate
concentration, perhaps partially explain-
ing the deleterious effect of cigarette
smoking on the esophagus. Salivary flow
increases in response to acid instillation
into the esophagus or to heartburn. This
esophagosalivary reflex is again afunction
ofage, and it appears thatas one gets older
this reflex increase in salivary flow rate
decreases. Helm et al. have suggested that
this esophagosalivary reflex is absent in
patients with severe esophagitis and,
hence, may play an important role in the
pathogenesis ofreflux disease.
ROLE OF HIATUS HERNIA IN
REFLUX ESOPHAGITIS
Is hiatus hernia important in reflux
disease? It is ironic that apparently such a
simple question has dodged us for so long.
In the 1950s and 1960s, hiatus hernia was
synonymous with reflux disease. In the
1970s and 1980s, it was not felt to be of
primary importance, but interest in its
pathophysiological role has reappeared in
the 1990s. The major deterrent to its
importance lies in its common presence in
asymptomatic subjects, and the observa-
tion that 5 percent to 20 percent ofpatients
with gastroesophageal reflux (GER)b do
not have hiatal hernias. However, one can-
not ignore the facts that more than 95 per-
cent of patients with significant GER dis-
ease (GERD) have hiatal hernias, and that
all successful antireflux operations
include reduction of hiatal hernia. The
Allison operation, which only reduces
hernias, is successful in a significant num-
ber ofpatients, and recurrence of the her-
nia is a common finding in patients with a
return of symptoms following antireflux
surgery. All of these arguments should
refocus our attention and research on the
pathophysiological significance ofhernias
in GERD.
Recent studies have focused on the
effect ofa hernia on acid clearance. Using
simultaneous esophageal pH monitoring
and scintiscanning, we found that normal-
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from the esophagus soon after its injection
eitherby primary (causedby the first swal-
low) or secondary peristalsis. However,
patients with a hiatal hernia retain a por-
tion ofthe injected bolus in the hernial sac.
This retained bolus re-refluxes with subse-
quent swallow-induced LES relaxations.
Thus, delayed disappearance of acid in
patients with a hiatal hernia is not delayed
clearance but is new reflux from the her-
nia.
Delayed acid clearance in patients
with reflux esophagitis and hiatal hernias
has been recognized by a number ofinves-
tigators. Booth et al. found this to be the
case and so did DeMeester et al. Stanciu
and Bennett found no correlation ofhiatus
hernia with acid clearance times.
However, Johnson reported accelerated
acid clearance after an antireflux operation
in patients with reflux esophagitis. Sloan
and Kahrilas have recently identified that
the reason for the heterogeneity in acid
clearance times with hiatus hernia is relat-
ed to the type ofhiatal hernia: reducible or
non-reducible. It is only the non-reducible
hernias that trap the bolus and demonstrate
re-reflux phenomena with the swallows
that are associated with delayed acid clear-
ance time. The reducible hernia, on the
other hand, does not impair the acid clear-
ance mechanism.
Better understanding of the role of
crural diaphragm at the esophagogastric
junction will most likely clarify the patho-
physiological significance ofhiatal hernias
in GERD. It is more than likely that the
hernia contributes to the pathophysiology
of reflux disease by other mechanisms, in
addition to impaired acid clearance.
McCallum andMittal, as well as Holloway
and Dent, have observed inspiration-relat-
ed reflux, which seems to occur exclusive-
ly in patients with hiatalhernias and severe
reflux disease. One mechanism by which
inspiration may induce GER could be
related to contraction of the crural
diaphragm. This contraction may lead to
compartmentalization of a part of the
stomach above the diaphragm, facilitating
reflux of the contents from a herniated
stomach into the esophagus. Despite the
current enthusiasm, I believe that careful
and prospective studies need to be per-
formedbefore one may acceptthe truerole
ofthe hernia in reflux disease.
The major limiting factor in hiatal
hernia research is the lack of perfect
methodology to identify and thus define
hiatal hernia. Most studies use barium
swallow and provocative maneuvers, such
as abdominal compression, to detect her-
nias. The maneuvers are often unphysio-
logical and do not distinguish between
reducible and non-reducible hernias.
Endoscopic diagnosis is subjective, and it
also does not address the issue of
reducibility. Manometry may be more
physiological than these other methods,
particularly a simultaneous pressure and
crural diaphragmatic electromyogram
(EMG) recording technique. This tech-
nique can precisely determine the location
ofthe LES, the crural diaphragm, andtheir
relationship to each other in a normal sub-
ject. A similar technique could be used to
detect hiatal hernias more precisely in
order to address the importance of hiatal
hernia in reflux disease.
WHAT ISTHE EFFECT OF
CHOLINERGIC STIMULATION ON
ESOPHAGEAL MOTILITY AND
CLEARANCE IN GERD?
The pharmacological basis of
esophageal peristalsis has been elucidated.
Esophageal peristalsis is the major mecha-
nism responsible for the clearance ofboth
the swallowed food bolus and the refluxed
gastric content. Primary swallowing-
induced peristalsis empties the food bolus,
while secondary peristalsis (induced by
the presence of gastric acid) clears
refluxed material, particularly at night. A
minimum contraction amplitude of 30
mmHg is required for clearance, which is
incomplete at lower contraction ampli-
tudes and when peristaltic progression of
the contraction fails.176 McCallum: Pharmacologic modulation ofmotility
Cholinergic stimulation is excitatory
to esophageal peristalsis while nitrergic
innervation is inhibitory. Experimental
studies in cats, monkeys and humans
demonstrate that atropine blockade
reduces the amplitude of esophageal con-
tractions and inhibits the progression of
the peristaltic wave from the striated mus-
cle to the smooth muscle. Atropine block-
ade has no effect on the propagation veloc-
ity in the smooth muscle itself. The
inhibitory role of nitric oxide can be
blocked by L-nitro-arginine-methyl-ester
and nitric oxide scavengers, such as
recombinant hemoglobin. Blockade of
nitric oxide inhibition produces a dramatic
increase in the propagation velocity of
esophageal contractions. In the smooth
muscle of the esophagus, nitric oxide-
medicated inhibitory neurones mainly
control the timing, and therefore the prop-
agation velocity, of esophageal contrac-
tions, where as cholinergic excitatory neu-
rones mainly determine the strength ofthe
contraction.
In the case of GERD, a substantial
number ofpatients have ineffective propa-
gation of the peristaltic wave as well as
reduced amplitude of the primary peri-
staltic wave. This decrease in amplitude
corresponds directly to the severity of
oesophagitis. In addition, patients with
GERD have higher thresholds for induc-
tion of secondary peristalsis than patients
without GERD.
In line with the pharmacological basis
ofesophageal peristalsis, cholinergic stim-
ulation improves the disordered motility
and clearance ofpatients with GERD. This
stimulation can be produced either by
bethanechol, which stimulates cholinergic
receptors, or by cisapride and ery-
thromycin, which act on receptors in the
amplitude of esophageal contractions, a
decrease in the propagation velocity ofthe
peristaltic contractions, and an improve-
ment in esophageal clearance and transit
time. In both normal subjects and GERD
patients, bethanechol increases the ampli-
tude of peristalsis, decreases the progres-
sion velocity of peristalsis, and improves
esophageal transit and clearance.
Bethanechol's effect on propulsive force is
unknown, although it does increase the
amplitude of secondary esophageal peri-
staltic contraction.
Cisapride increases the amplitude and
propagation velocity of peristalsis in nor-
mal patients and those with GERD. It
accelerates the axial propagation and
increases the overall contraction lengths of
the peristaltic wave. However, it has not
been found to reduce the rate offailed pri-
mary peristalsis in severe GERD patients.
The clearance time of postprandial reflux
in GERD is decreased by cisapride; how-
ever, the effect of cisapride on secondary
esophageal peristalsis has not been studied
extensively. Erythromycin does not affect
the amplitude of peristalsis in normal
patients or GERD patients, but does
reduce the progression velocity and tends
to improve peristaltic performance in
GERD. The effects of erythromycin on
propulsive force and secondary contrac-
tions are unknown.
All these motility drugs are less effec-
tive in severe cases of reflux esophagitis
when nerves and/or muscles are diseased.
SPHINCTER MECHANISM AT
GASTROESOPHAGEAL JUNCTION
The movement of gastric contents
into the esophagus is prevented by the
sphincteric mechanism at the gastroe-
sophageal junction (GEJ), the major
antireflux barrier. The intraluminal pres-
sure at the GEJ determines the strength of
this antireflux barrier. Recent studies indi-
cate that the smooth muscles of the lower
esophageal sphincter (LES) and skeletal
muscles of the crural diaphragm con-
tribute to the GEJ pressure. Because the
LES and crural diaphragms are anatomi-
cally superimposed on each other, the
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cannot distinguish between the contribu-
tions from the two structures. The evi-
dence of the contribution of the crural
diaphragm to the GEJ pressure requires
simultaneous recordings of GEJ pressure
and EMG ofthe crural diaphragm.
The pressure at the GEJ varies during
inspiration and expiration. The end expira-
tory pressure is causedby the smooth mus-
cles of the LES, and the inspiratory
increase is caused by the active contrac-
tion of the crural diaphragm. This latter
observation has been confirmed in animal
studies as well as human studies. The
increase in the GEJ pressure during inspi-
ration is directly proportional to the force
of inspiration, or in other words, the force
of the crural diaphragm contraction. The
LES and crural diaphragm reflexively con-
tract to a number of other stimuli.
Increases in intra-abdominal pressure,
caused by either abdominal compression
or straight-leg raises, cause reflex contrac-
tions of the crural diaphragm. The LES
also reflexively contracts in response to
increased intra-abdominal pressure. The
LES pressure also is related to gastric
motility and increases with its migrating
motor complex (MMC) activity. The LES
pressure is at its peak during phase 3 and
lowest during phase 1 of the MMC activi-
ty. It is reasonable to assume that the
increase in LES pressure during phase 3 of
the MMC activity is required to counteract
the increase in gastric pressure caused by
gastric contraction.
GASTROESOPHAGEAL MOTOR
EVENTSTHAT FACILITATE
GASTROESOPHAGEAL REFLUX
The ability to monitor LES pressure
continuously using a Dent sleeve has
greatly expanded our knowledge of the
motor events associated with episodes of
GER. Initial studies by Dent et al., and
subsequently a number of investigators,
have shown that the prerequisite for GER
to occur is low LES pressure. This low
LES pressure can be caused by either a
defective basal LES tone or more com-
monly by a transient inhibition ofthe nor-
mal LES tone. The latter has been given
the name oftransient LES relaxations. The
characteristics of transient LES relaxation
differ from the swallow-associated LES
relaxation as follows: (1) transient LES
relaxation is usually longer than 10 sec in
duration compared with a swallow-associ-
ated LES relaxation that is 7 to 8 sec, and
(2) transient LES relaxation is not associ-
ated with a full oropharyngeal event as
documented by an absence offull pharyn-
geal,contraction or mylohyoid EMG com-
plex. However, a partial pharyngeal con-
traction and/or a small mylohyoid EMG
complex can be identified at the onset of
30 percent to 50 percent of the transient
LES relaxations. The pathogenetic impli-
cations of defective basal tone differ from
transient LES relaxation. A defective basal
LES tone implies a myogenic defect and
GER under this setting is apassive process
that occurs because of a normally present
gastroesophageal pressure gradient that is
4 to 6 mm Hg in the end expiratory state
and 10 to 12 mm Hg during a tidal inspi-
ration. On the other hand, transient LES
relaxation is an active inhibition ofthe pre-
existing LES tone and implies a defective
neurogenic control. It appears that tran-
sient LES relaxation is mediated through
the brain stem via the vagus nerve.
Recent studies suggest that transient
LES relaxation, even though initially
thought to be an isolated event in the LES,
is associated with a number of other exci-
tatory and inhibitory motor events. The
excitatory events can be recognized in the
esophagus andusually observed as alocal-
ized or diffuse simultaneous esophageal
contraction. The crural diaphragm remains
relaxed during transient LES relaxation,
and one may also note inhibition ofgastric
tone. It appears that transient LES relax-
ation is a response to a programmed set of
events in the central nervous system, most
likely in the brain stem. However, a corti-
cal influence must be necessary because
transient LES relaxation is absent during
sleep.178 McCallum: Pharmacologic modulation ofmotility
The myogenic defect in the LES caus-
ing a defective basal LES tone is classical-
ly observed in scleroderma and is thought
to be caused by atrophy of the smooth
muscles. However, the reason for a defec-
tive basal LES tone in the common variety
of reflux disease is not known. The defect
in basal tone is either in the form of a per-
sistently low LES pressure or a gradual
drifting of normal tone to low pressures
for periods of 30 to 60 seconds or longer.
It is possible that the defective basal tone
in the common variety reflux disease may
result from the damage caused by reflux
esophagitis. The healing ofesophagitis by
omeprazole does not improve the basal
LES tone, an argument against that theory.
Nevertheless, it is possible that LES mus-
cle, once damaged, may not be able to
recover. Another theory is that a certain
few percent ofpeople areborn with a weak
or defective LES pressure - hence reflux
of infancy, and this, in turn, predisposes
adults.
It appears that only a minority of
patients with GER disease have a defec-
tive basal tone. These patients tend to
have severe esophagitis. More commonly,
transient LES relaxation is identified as
the mechanism for GER that implies a
defective neural control. However, it is
difficult to think of transient LES relax-
ation as a manifestation of a neurogenic
defect because it is the mechanism for
belching and can be recorded fairly fre-
quently in normal healthy individuals. A
given patient may reflux exclusively by
either the mechanism of transient LES
relaxation or defective basal LES tone.
However, there are some patients in whom
both mechanisms of reflux are operative.
What is the stimulus for transient LES
relaxation? Two sites that have been impli-
cated are gastric distention andmechanical
stimulation of the pharynx. The observa-
tion that transient LES relaxations and
GER occur more frequently in the post-
prandial period suggest that gastric disten-
tion is important. Furthermore, gastric dis-
tention by a balloon increases the frequen-
cy of transient LES relaxation. On the
other hand, transient LES relaxation can
be recorded fairly frequently on an empty
stomach and the frequency of transient
LES relaxation is not consistently higher
after a meal. We have recently observed
that a catheter in the pharynx increases the
frequency of transient LES relaxation,
suggesting a role for pharyngeal receptors
as the site of stimulus. A number of ques-
tions regarding transient LES relaxations
remain unanswered: (1) Does the frequen-
cy of transient LES relaxation account for
the difference between a normal subject
and a, patient? (2) What pharmacology
explains the stimulus for transient LES
relaxation? (3) If there were no manomet-
ric catheters and pH probes traversing the
pharynx, would transient LES relaxation
be recorded as the major mechanism of
GER?
WHAT ISTHE RELATIONSHIP OF
DELAYED GASTRIC EMPTYINGTO
GERD?
Gastric stasis may contribute to the
pathogenesis of reflux disease by increas-
ing all of the following factors: postpran-
dial gastric distension, volume ofintragas-
tric content available for reflux, gastro-
esophageal pressure gradient and frequen-
cy of transient lower esophageal sphincter
relaxations (TLESRs).
About 80 percent of patients with
endoscopy or ph-metry-proven GERD
have vomiting or other dyspeptic symp-
toms (postprandial satiety, fullness, bloat-
ing, epigastric pain, belching nausea, and
even vomiting) suggestive ofgastric stasis.
However, the predictive value of these
symptoms for the presence ofdocumented
gastric stasis is very poor. Scintigraphic
studies (or other validated methods for the
measurement of gastric emptying) are,
therefore, the only reliable way ofevaluat-
ing the frequency of gastric stasis in
GERD. Among 20 studies including 670
patients, in which objective evaluation of
gastric emptying was performed, 14 con-
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emptying was present in GERD patients.
Among 10 studies that considered the
emptying of both solids and liquids, three
concluded that there was no delay in gas-
tric emptying, four that stasis was present
for liquids and solids, two that stasis was
present for solids only, and one that stasis
occurred with liquids only. In summary,
our data indicate that gastric stasis was
found in about 40 percent ofpatients with
GERD, and solids are mainly affected.
In most published studies, there is no
clearcorrelation between the presence and
intensity of gastric stasis and the presence
and severity of the reflux, or between the
lower esophageal sphincter pressure and
the intensity of the stasis. However,
Miscali et al. have found a linear relation-
ship between the severity of oesophagitis
and the delay in gastric emptying.
In atherapeutic study ofthe cause and
effect relationship between stasis and
reflux, the prevalence of stasis was higher
in patients resistant to medical treatment.
However, it has been shown that ery-
thromycin improves gastric emptying but
has no effect on esophageal acid exposure.
Rather than being a causal factor, gastric
stasis could therefore be an associated dis-
order in patients with GERD. In clinical
practice, gastric emptying studies are
important in the management of GERD
patients not responding to medical therapy
and when surgery is being considered.
WHAT ISTHE RELATIONSHIP
BETWEENTRANSIENT LOWER
ESOPHAGEAL SPHINCTER
RELAXATIONS AND DELAYED
GASTRIC EMPTYING?
In normal patients, only 30 percent of
TLESRs are associated with acid reflux.
This proportion increases to about 60 per-
cent in patients with reflux disease.
Postprandially, there is an increase in the
frequency of TLESRs that is more pro-
nounced in patients with reflux disease.
Experimental studies have shown that gas-
tric distension is a potent trigger for
TLESRs, and in this respect, the cardia is
more sensitive to gastric distension than
the distal stomach. It is possible that there
are differences in the behavior ofthe prox-
imal stomach between patients with
GERD and normal subjects, and the pres-
sure of a hiatus hernia altering the fundic
stretch receptor thresholds could be the
explanation.
As well as emptying from the stom-
ach as a whole, recent studies suggest that
there is abnormal retention of both solids
and liquids in the proximal stomach. A
correlation between the number of post-
prandial TLESRs and the amount ofmate-
rial retained in the proximal stomach has
been demonstrated. Fundoplication has
been shown to improve proximal gastric
emptying of solids and liquids in addition
to reducing the number of TLESRs.
Therefore, there is some preliminary evi-
dence that delayed gastric emptying is
associated with an increase in the number
ofTLESRs.
WHICH OFTHE
PHARMACOLOGICAL EFFECTS OF
CISAPRIDE REALLY CONTRIBUTE
TO ITS EFFICACY INTREATING
GERD?
Clinical pharmacological studies in
healthy volunteers and patients with
GERD have shown that cisapride has a
wide range of pharmacological effects on
the upper gastrointestinal tract. These
include:
* Increase in fasting and
postprandial lower esophageal
sphincter pressure.
* Stimulation ofesophageal
peristalsis (increase in number,
duration and amplitude of
esophageal waves and in
propagation velocity).
* Increase in propulsive force after
distension.
* Stimulation of salivary secretion
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* Improvement in esophageal
clearance and emptying.
* Reduction in distal esophageal
exposure to acid.
* Improvement in gastric motility
and emptying.
The extent and duration ofeach ofthe
pharmacological effects of cisapride
depend on the experimental conditions
under which they are studied. The main
reasons for the discrepancies in findings
are different methodologies and different
selection criteria for the subjects investi-
gated.
The reduction in esophageal exposure
to acid, which allows symptomatic
improvement and mucosal healing, is
clearly a result of increased esophageal
clearance due to the stimulation of
esophageal peristalsis and salivary secre-
tion as well as to the increase in sphincter
resistance. Esophageal exposure to acid
seems to depend on the gastric emptying
rate and gastric emptying is often delayed
in patients with GERD. In GERD patients
with delayed gastric emptying, the pH is
less than 4 for longer than in patients
whose emptying rate is normal. In patients
with gastric motor derangement, a signifi-
cant correlation was found between the
emptying half-life and the reflux time.
Similarly, in a group of patients undergo-
ing antireflux surgery, those with delayed
gastric emptying had a significantly high-
er esophageal exposure to acid than did
patients without gastric motor derange-
ment.
Administration of cisapride before
meals significantly accelerated gastric
emptying ofsolids in both healthy individ-
uals and patients with GERD. The post-
prandial esophageal exposure to acid was
significant in the subgroup ofpatients with
a delayed emptying rate. The same holds
true for the duration of reflux episodes.
Therefore, cisapride accelerates gastric
emptying in reflux patients and strongly
reduces esophageal exposure to acid. This
lasteffect isparticularly evident inpatients
with delayed gastric emptying, probably
because ofthe ability ofthe drug to correct
both esophageal and gastric motor disor-
ders.
To summarize, the stimulation ofboth
esophageal and gastric motility is an
important determinant of cisapride effica-
cy in GERD. The improvement of
esophageal clearance, the increase in
sphincter resistance, and the acceleration
in gastric emptying, with a consequent
reduction in the gastric volume available
forreflux, all contribute to thereduction of
esophageal exposure to acid, which ulti-
mately allows symptomatic relief and
mucosal healing.